Novel Oral Therapy Demonstrates Superior Glycemic Control and Weight Reduction in Type 2 Diabetes Patients Compared to Existing Oral GLP-1 Analogues
A groundbreaking daily pill, identified as orforglipron, has emerged from a pivotal clinical investigation, revealing a significant advancement in managing type 2 diabetes and...
